Karnataka GST authority raises about 13 crore demand for FY 2020-21

Regulatory & Legal View source PDF Explain this filing

SAILIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.3%Reaction day

₹878.00

prior close

₹860.00

announcement price

In-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-2.3%-0.0% vs market

Pharmaceuticals peers, median of 156sector-2.0%-0.3% vs sector

On the reaction day the stock moved in line with Nifty Smallcap 250 and 0.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.2

10m

+0.0

15m

+0.0

30m

-0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.3-2.3-0.0-2.0-0.3

Next day

+0.3-1.3+1.6-1.4+1.7

+1.5-2.0+3.4-1.4+2.9

+3.4-1.4+4.8-1.0+4.4

+2.5-0.6+3.1-0.8+3.3

+3.3-0.2+3.5-0.6+3.9

+0.2-1.7+2.0-2.1+2.4

15d

+4.2-0.0+4.2-2.1+6.2

+8.5-0.0+8.5-1.4+9.9

+1.7-1.4+3.1-5.2+6.9

+15.3-8.7+24.0-11.8+27.1

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Joint Commissioner of Commercial Taxes (Appeals), Kalaburagi passed an order on December 6, 2025 against Sai Life Sciences under Section 107(11) of the Karnataka and Central GST Acts. The demand includes IGST of about 4.62 crore, interest of about 3.21 crore, penalty of about 93 lakh, and cess of about 2.9 lakh, totaling close to 13 crore. The demand relates to alleged excess ITC claim and mismatch between B2B supply and sale-purchase register for FY 2020-21. The company plans to appeal at the Tribunal level.

Likely market impact

Order contested via appeal; company expects no material financial impact. Watch for Tribunal outcome.